FWP

Forefront Wealth Partners Portfolio holdings

AUM $239M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+16.11%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$211M
AUM Growth
-$186M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
210
New
Increased
Reduced
Closed

Sector Composition

1 Technology 13.09%
2 Consumer Discretionary 2.88%
3 Financials 2.35%
4 Industrials 2%
5 Communication Services 2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBEF icon
151
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$8.63B
-64,146
DHR icon
152
Danaher
DHR
$125B
-1,475
DJP icon
153
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$820M
-219,140
EDV icon
154
Vanguard World Funds Extended Duration ETF
EDV
$4.01B
-108,119
EES icon
155
WisdomTree US SmallCap Earnings Fund
EES
$683M
-17,832
EMLP icon
156
First Trust North American Energy Infrastructure Fund
EMLP
$3.97B
-259,434
EW icon
157
Edwards Lifesciences
EW
$48.5B
-4,492
FLOT icon
158
iShares Floating Rate Bond ETF
FLOT
$9.26B
-45,126
FLRN icon
159
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$2.82B
-112,253
GBTC icon
160
Grayscale Bitcoin Trust
GBTC
$30.8B
-2,425
GERN icon
161
Geron
GERN
$961M
-52,258
HDV
162
iShares Core High Dividend ETF
HDV
$13.3B
-38,137
HEEM icon
163
iShares Currency Hedged MSCI Emerging Markets
HEEM
$250M
-47,743
HYG icon
164
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.6B
-9,267
IAU icon
165
iShares Gold Trust
IAU
$75.6B
-16,201
IBTJ icon
166
iShares iBonds Dec 2029 Term Treasury ETF
IBTJ
$1.24B
-16,162
IEF icon
167
iShares 7-10 Year Treasury Bond ETF
IEF
$48.7B
-22,027
MDT icon
168
Medtronic
MDT
$107B
-4,279
MREO
169
Mereo BioPharma
MREO
$46.3M
-33,180
MTUM icon
170
iShares MSCI USA Momentum Factor ETF
MTUM
$23.8B
-37,777
NKTX icon
171
Nkarta
NKTX
$208M
-39,452
ONTO icon
172
Onto Innovation
ONTO
$15.3B
-2,591
PFE icon
173
Pfizer
PFE
$154B
-12,830
RCAT icon
174
Red Cat Holdings
RCAT
$1.43B
-29,000
REGN icon
175
Regeneron Pharmaceuticals
REGN
$79.5B
-579